Julie Drapier is the CEO and founder of Impetus Finance, an international advisory firm that transforms breakthrough innovation into impactful businesses in developed and emerging markets. Impetus partners with impact & strategic investors, blue chip corporates, startups and small businesses to spur innovation while achieving superior financial, social, environmental or strategic returns.
In this capacity, Julie representsAir Liquide Venture Capital on the Board of Cellnovo (E-health- Euronext), Rapid Oxygen (Medtech) and Proxem (AI-Big Data). Julie is also a Venture Partner at NextGen VP and is mentoring a number of start-ups either directly orvia public (NETVA), private or academic (UMD,Insead , ESCP Blue Factory or I-Corps) accelerators. Julie is an angel investor in EverlyWell and Caeden.
Prior to that, Julie managed Air Liquide Corporate Venture’s investments in the cleantech, healthcare, and digital sectors in Europe, North America and Australia from origination to closing and exit. In this capacity, Julie sourced or assessed more than 200 start-ups and led investments in more than 10 of them at stages ranging from seed to IPO.
For more than 15 years, Julie has been helping companies raise capital and structure complex projects globally, including public private partnerships, transportation projects and carbon reduction initiatives. Julie piloted the Air Liquide Group’s first carbon reduction projects (CDM and JI), she has also structured or invested in infrastructure projects globally with Meridiam Infrastructure Fund and DexiaAstris Finance.
Julie is based out of Washington, DC and is a graduate of the Ecole Supérieure de Commerce of Paris (ESCP). Julie also holds an MBA from Insead and is fluent in English, Spanish, and French.